Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, Par Value $0.001
-
Shares outstanding
-
12,939,536
-
Total 13F shares
-
14,076,479
-
Share change
-
-48,671
-
Total reported value
-
$20,411,792
-
Price per share
-
$1.45
-
Number of holders
-
57
-
Value change
-
-$85,175
-
Number of buys
-
23
-
Number of sells
-
21
Institutional Holders of Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR) as of Q4 2020
As of 31 Dec 2020,
Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,076,479 shares.
The largest 10 holders included
NEA Management Company, LLC, BlackRock Inc., Aisling Capital Management LP, VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, RENAISSANCE TECHNOLOGIES LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and Nuveen Asset Management, LLC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.